iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

NASHUA, N.H.,
Feb. 14, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that it will release financial results for the fourth quarter and
year ended December 31, 2021, after the market close, and host a conference
call at 4:30 PM Eastern Time on Monday, February 28.

Monday,
February 28th at 4:30 PM ET

https://themediaframe.com/mediaframe/webcast.html?webcastid=ELUrpENc

About
iCAD, Inc.
Headquartered
in Nashua, NH, iCAD is a global medical technology leader providing innovative
cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:

Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor
Inquiries:
iCAD Investor Relations
ir@icadmed.com